NASDAQ$BNKK
Bonk Inc · Q1 2025 earnings
Q1 2025 earnings · · Before market open · Investor relations
Briefing
BNKK reported Q1 2025 revenue of $42.1K, a net loss of $5.3M, diluted EPS of $-0.08.
For Q1 2025, BNKK reported Revenue was $42.1K, net loss was $5.3M, diluted EPS was $-0.08. The quarterly filing discusses operating priorities, liquidity, and sector-specific risks in MD&A.
- Revenue $42.1K for Q1 2025.
- Net loss $5.3M.
- Diluted EPS $-0.08.
Headline financials
Revenue & EPS history
Safety Shot · Revenue · Quarterly
$42.1K
Revenue by segment
Safety Shot · $203K total across 1 segment · Q4 2023
- Dietary Drink Supplement$203K—100.0%
Forward guidance
Outlook emphasizes clinical milestones, cash runway, and operating expense discipline.
Tailwinds
- Pipeline progress and partnership optionality.
- Cost controls and balance-sheet flexibility.
Headwinds
- Operating losses until commercialization.
- Trial timing and regulatory uncertainty.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2025
+4.2%
Avg return
Earnings day
+0.7%
Avg return
5 days after
+4.1%
Avg return
30 days after
44%
11 / 25 earnings
Positive
+39.5%
Q3 2023
Best reaction
-9.0%
Q3 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.7% | -5.4% | -39.9% | |
| Q3 2025 | -4.0% | -18.4% | -33.3% | |
| Q2 2025 | +5.4% | -20.3% | -37.0% | |
| Q1 2025 | -6.1% | -30.3% | -23.5% | |
| Q3 2024 | +0.8% | -2.0% | -12.1% | |
| Q2 2024 | +13.5% | +25.4% | +133.2% | |
| Q4 2023 | -2.4% | -8.6% | -19.5% | |
| Q1 2024 | +8.1% | +0.7% | -14.0% | |
| Q3 2023 | +39.5% | +110.1% | +80.7% | |
| Q2 2023 | +13.5% | +8.7% | +30.8% | |
| Q1 2023 | -3.1% | -4.8% | -22.9% | |
| Q4 2022 | -0.2% | -1.8% | -1.1% | |
| Q3 2022 | +0.8% | -4.7% | -22.3% | |
| Q2 2022 | -1.7% | +4.4% | +54.4% | |
| Q1 2022 | -6.8% | -9.4% | -6.8% | |
| Q4 2021 | -6.8% | -9.4% | -6.8% | |
| Q3 2021 | -9.0% | -16.2% | -7.2% | |
| Q2 2021 | -8.5% | -7.3% | -10.7% | |
| Q1 2020 | +10.4% | +6.0% | +6.9% | |
| Q1 2021 | -0.2% | -10.6% | -16.8% | |
| Q2 2020 | -0.2% | -10.6% | -16.8% | |
| Q4 2020 | -0.2% | -10.6% | -16.8% | |
| Q4 2019 | +22.0% | +11.1% | +34.4% | |
| Q3 2020 | +22.0% | +11.1% | +34.4% | |
| Q3 2019 | +22.0% | +11.1% | +34.4% | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro